Off-Label Dissemination Still Must Disclose Interest, Unapproved Status
This article was originally published in The Gray Sheet
Executive Summary
Judge Royce Lamberth's ruling in the WLF v. Henney case leaves intact some of FDA's authority over off-label dissemination.
You may also be interested in...
WLF Will Use FDA Notice On Circuit Court Ruling As Wedge To Reopen Case
FDA's intention to use journal reprints distributed for off-label indications as evidence in misbranding enforcement actions violates the standing injunction on two "enduring materials" guidance documents, the Washington Legal Foundation contends.
WLF Will Use FDA Notice On Circuit Court Ruling As Wedge To Reopen Case
FDA's intention to use journal reprints distributed for off-label indications as evidence in misbranding enforcement actions violates the standing injunction on two "enduring materials" guidance documents, the Washington Legal Foundation contends.
WLF Decision Opens Door To Off-Label Promotion With Journal Reprints
Manufacturers can promote products for off-label uses with studies sponsored by competitors, according to the July 28 federal court decision against the FDA Modernization Act in Washington Legal Foundation v. Henney.